drugset / Trial / NCT00555230

Effects of HMG-coA Reductase Inhibitor on Rheumatoid Arthritis

NCT00555230

Phase 2 Completed 150 enrolled Chinese University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is: 1. To evaluate the prevalence of preclinical atherosclerosis in Chinese patients with RA compared to healthy controls. 2. To determine those clinical and biological measures that best predict the presence of plaque and increased arterial stiffness. 3. To ascertain the efficacy and safety of rosuvastatin in the prevention of atherosclerosis in patients with RA measured by carotid intima-media thickness (IMT) and pulse wave velocity (PWV).

Timeline

Start
2007-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg

Indications